Open Access. Powered by Scholars. Published by Universities.®

Biochemistry, Biophysics, and Structural Biology Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 6 of 6

Full-Text Articles in Biochemistry, Biophysics, and Structural Biology

Novel G-Dna Binding Proteins From The Ciliate Tetrahymena Thermophila: Purification, Characterization, Cloning And Functional Analyses , Quan Lu Jan 1999

Novel G-Dna Binding Proteins From The Ciliate Tetrahymena Thermophila: Purification, Characterization, Cloning And Functional Analyses , Quan Lu

Retrospective Theses and Dissertations

G-DNA is a family of novel four-stranded DNA structures characterized by motifs called G-quartets. Evidence is growing to suggest that G-DNA exists and plays biological roles in vivo. In order to further elucidate the functions of G-DNA, we have studied proteins that specifically bind to the DNA structure;Two G-DNA binding activities, TGPI and TGP3, were purified from the ciliate Tetrahymena thermophila. Based on the peptide sequences obtained from direct internal peptide sequencing, the cDNAs coding for the genes were cloned. Deduced protein sequences showed that TGP1 and TGP3 are novel proteins but share significant homology with each other. Furthermore ...


Evaluation Of Mycobacterial Esat-6 As A Type-I Immune Enhancing Adjuvant , Sreekumar Ambalakkat Menon Jan 1999

Evaluation Of Mycobacterial Esat-6 As A Type-I Immune Enhancing Adjuvant , Sreekumar Ambalakkat Menon

Retrospective Theses and Dissertations

The need for improved adjuvants has continued in spite of new vaccination strategies using recombinant proteins and genetic (DNA vectored) vaccines. The Mycobacterium tuberculosis protein ESAT-6 has been shown in mice to be involved in the recall of long-lived immunity and protection in mice against tuberculosis. Thus, this protein could potentially act as a molecular adjuvant enhancing antigen-specific Type I immune responses. This study examined the hypothesis that Es could enhance Type I responses against a second antigen in mice when presented as a fusion with that antigen. This was tested using ESAT-6 fusions with two Mycoplasma hyopneumoniae surface antigens ...


Genetic And Molecular Characterization Of The Rev Protein Of Equine Infectious Anemia Virus , Michael Andrew Belshan Jan 1999

Genetic And Molecular Characterization Of The Rev Protein Of Equine Infectious Anemia Virus , Michael Andrew Belshan

Retrospective Theses and Dissertations

Members of the lentivirus subfamily of retroviruses are characterized as causing slow, chronic disease. Atypical of other lentiviruses, such as human immunodeficiency virus type 1, equine infectious anemia virus (EIAV) may produce a rapid, variable disease course in horses. Infected horses may undergo an, acute episode of disease involving viremia, fever, and thrombocytopenia. Following this acute period, horses may resolve to an inapparent infection or suffer a chronic period of additional cycles of viremia, fever, and thrombocytopenia. Horses which survive clinical episodes usually become inapparent carriers of the virus for life. Numerous virus and host factors contribute to the phenotypic ...


Genetic Mobility And Instability Of Retroviral Vector In Vector Producer Cells For Gene Therapy, Won-Bin Young Jan 1999

Genetic Mobility And Instability Of Retroviral Vector In Vector Producer Cells For Gene Therapy, Won-Bin Young

Retrospective Theses and Dissertations

A primary biosafety issue of retroviral vector-mediated gene therapy is the genetic instability of retroviral vectors. Reverse transcription of vector RNA genome is initiated by viral reverse transcriptase (RT) in a virion particle after infection of a target cell. During reverse transcription, abnormal template switches between vector and occasionally co-packaged helper virus in a virion particle can therefore enable helper virus to regain replication elements from the vector and revert to replication-competent retrovirus (RCR). This research was undertaken to study the origins of RT enzyme activities and test the hypothesis that RT enzyme activities are contributed by both exogenous RT ...


The Glycogen Phosphorylase/ Phosphorylase Kinase Interaction: Effects Of Mutations In The Amino-Terminal Region Of Glycogen Phosphorylase , Alyssa Christine Biorn Jan 1999

The Glycogen Phosphorylase/ Phosphorylase Kinase Interaction: Effects Of Mutations In The Amino-Terminal Region Of Glycogen Phosphorylase , Alyssa Christine Biorn

Retrospective Theses and Dissertations

Glycogen phosphorylase is an important enzyme for carbohydrate metabolism in muscle. It uses inorganic phosphate to remove glucose from glycogen, producing glucose-1-phosphate, which can be used for the production of ATP. Inactive glycogen phosphorylase (phosphorylase h) is activated either by the allosteric binding of 5'-AMP, or by phosphorylation by phosphorylase kinase (PhK). Phosphorylation produces phosphorylase a, which is active in the absence of AMP. PhK is the only kinase that can phosphorylate phosphorylase b, which in turn is the only substrate for PhK. This dissertation research has attempted to determine the reasons for this specificity and how these two ...


Biochemical Characterization Of Tractin And Leechcam, Two Ig-Superfamily Members Involved In Regulation Of Axonal Outgrowth Of Leech Neurons , Chunfa Jie Jan 1999

Biochemical Characterization Of Tractin And Leechcam, Two Ig-Superfamily Members Involved In Regulation Of Axonal Outgrowth Of Leech Neurons , Chunfa Jie

Retrospective Theses and Dissertations

Tractin and LeechCAM are two recently identified members of the Ig-superfamily. Tractin has a highly unusual domain organization: 6 Ig-like domains, 4 FNIII-like domains, an acidic domain, 12 repeats of a novel proline- and glycine- rich motif with sequence similarity to collagen, a transmembrane domain, and an intracellular tail with an ankyrin and a PDZ-domain binding motif. Our data show that Tractin is proteolytically processed into four fragments at two cleavage sites: one located in the third FNIII domain, and the other one located just proximal to the transmembrane domain. The most NH2-terminal fragment is shown to be glycosylated with ...